Skip to Main Content

Author Details

Theresa Guo
Moores Cancer Center, University of California
2012
46
23
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37304550Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy.Transl Cancer Res2023
37304550Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy.Transl Cancer Res2023
36059671Current perspectives on recurrent HPV-mediated oropharyngeal cancer.Front Oncol2022
36059671Current perspectives on recurrent HPV-mediated oropharyngeal cancer.Front Oncol2022
33471396Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers.Cancer2021
33491747Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.Int J Oncol2021
33738875Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.Head Neck2021
33471396Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers.Cancer2021
34548317Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription.Clin Cancer Res2021
33491747Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.Int J Oncol2021
33738875Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.Head Neck2021
34548317Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription.Clin Cancer Res2021
32342570Overview of COVID-19 testing and implications for otolaryngologists.Head Neck2020
31949145Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.Nat Commun2020
31721164A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.Cancer2020
32342570Overview of COVID-19 testing and implications for otolaryngologists.Head Neck2020
32164487Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma.Epigenetics2020
32041482Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.Otolaryngol Head Neck Surg2020
32459061Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.Head Neck2020
32706401Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer.Cancer2020
32848210HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.Oncogene2020
32666664Impact of the COVID-19 pandemic on Otolaryngology trainee education.Head Neck2020
31721164A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.Cancer2020
31949145Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.Nat Commun2020
32041482Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.Otolaryngol Head Neck Surg2020
32706401Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer.Cancer2020
32848210HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.Oncogene2020
32666664Impact of the COVID-19 pandemic on Otolaryngology trainee education.Head Neck2020
32459061Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.Head Neck2020
32164487Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma.Epigenetics2020
30626753Variations in HPV function are associated with survival in squamous cell carcinoma.JCI Insight2019
31636280Differentially Methylated Super-Enhancers Regulate Target Gene Expression in Human Cancer.Sci Rep2019
30626753Variations in HPV function are associated with survival in squamous cell carcinoma.JCI Insight2019
31142745Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
31097695Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
30933315Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.Cancer2019
31636280Differentially Methylated Super-Enhancers Regulate Target Gene Expression in Human Cancer.Sci Rep2019
31097695Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
31142745Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
30933315Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.Cancer2019
29342249Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer.Bioinformatics2018
30118659Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinoma.Transl Res2018
30070359Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.Int J Cancer2018
29909892HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.Oral Oncol2018
29945995Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.Clin Cancer Res2018
29342249Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer.Bioinformatics2018
29146722The <i>NOTCH4</i>-<i>HEY1</i> Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2018
29945995Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.Clin Cancer Res2018
29909892HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.Oral Oncol2018
30070359Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.Int J Cancer2018
  • 1 - 50 of 92

Recommended Authors

Eric Di Gravio
University of Western Ontario
Career Start Year 2018
Number of shared co-authors 0
Steven F Gameiro
McMaster Immunology Research Centre, McMaster University
Career Start Year 2017
Number of shared co-authors 0
Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 0
Morgan Black
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2014
Number of shared co-authors 0
Neil Mundi
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Mushfiq H Shaikh
University of Western Ontario
Career Start Year 2013
Number of shared co-authors 0
Giananthony Rizzo
Western University
Career Start Year 2013
Number of shared co-authors 0
Hua Li
University of California san francisco
Career Start Year 2013
Number of shared co-authors 3
Krupal B Patel
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 0
Farhad Ghasemi
Western University
Career Start Year 2012
Number of shared co-authors 0
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 0
Julie E Bauman
George Washington University
Career Start Year 2007
Number of shared co-authors 10
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 3
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 0
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Natalia Issaeva
The University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 1
Anthony C Nichols
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 4
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 2
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 18
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 1
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 7
Mark W Lingen
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 7
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 4
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 4
Jennifer R Grandis
University of California san francisco
Career Start Year 1988
Number of shared co-authors 17
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 2
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 6
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 4
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Career Start Year 1986
Number of shared co-authors 2

Collaborators

Joseph A Califano
University of California
Co-authored papers 26
Daria A Gaykalova
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers 16
Elana J Fertig
Johns Hopkins University School of Medicine
Co-authored papers 14
Shuling Ren
Beijing Friendship Hospital, Capital Medical University
Co-authored papers 12
Alexander V Favorov
Johns Hopkins School of Medicine
Co-authored papers 12
Akihiro Sakai
Tokai University
Co-authored papers 10
Wayne M Koch
Johns Hopkins University School of Medicine
Co-authored papers 10
Chao Liu
Xiangya Hospital, Central South University
Co-authored papers 9
Mizuo Ando
University of Tokyo
Co-authored papers 9
Zubair Khan
University of Texas at Houston Health Science Center
Co-authored papers 9
Justin A Bishop
UT Southwestern Medical Center
Co-authored papers 9
Takahito Fukusumi
Osaka University Graduate School of Medicine
Co-authored papers 9
Michael J Considine
Johns Hopkins University School of Medicine
Co-authored papers 8
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Co-authored papers 8
Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Co-authored papers 7
Sayed Sadat
Moores Cancer Center, University of California San Diego
Co-authored papers 7
William H Westra
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 7
Patrick K Ha
University of California San Francisco
Co-authored papers 7
Sunny Haft
Moores Cancer Center, University of California
Co-authored papers 6
Yuki Saito
Niigata Prefectural Tokamachi Hospital.
Co-authored papers 6
Guorong Xu
Chinese University of Hong Kong
Co-authored papers 6
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 4
Susan R Davis
Co-authored papers 4
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 4
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
John Pang
University of Washington
Co-authored papers 4
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 4
Release 1.2